2011, Number 1
<< Back Next >>
Rev Cent Dermatol Pascua 2011; 20 (1)
Infantile rosacea
Rodríguez AM, Martínez MJÁ
Language: Spanish
References: 14
Page: 18-21
PDF size: 308.77 Kb.
ABSTRACT
Although rosacea was described many years ago, its etiology remains poorly understood. Different hypotheses have been described in order to understand this. The most important theories are those related to vascular disorders or alterations that play an essential role in its development. In this article we report the case of a 9 year-old girl with rosacea, and we made a review of the most recent advances in its etiology, pathogenesis and treatment, keeping in mind the medicine based on evidence.
REFERENCES
Wilkin JK. Rosacea. Pathophysiology and treatment. Arch Dermatol 1994; 130: 359-362.
Ryan TJ. Biochemical consequences of mechanical forces generated by distention and distortion. J Am Acad Dermatol 1990; 21: 115-130.
Fitzpatrick TB. Dermatología en medicina general. 1997: 762-771.
Rook. Textbook of dermatology. Rosacea, 2104-2110.
Berg M. An, Liden S. Epidemiologic study of rosacea. Acta Derm Venereol 1989; 69: 419-423.
Bonnar E. The Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28: 443-448.
Hirschman JV. Does Helicobacter pylori have a role in the pathogenesis of rosacea? J Am Acad Dermatol 2000; 42: 537-539.
Grilli R. Helicobacter pylori: related to rosacea? JAAD 2000; 42: 532-537.
Thiboutout D. Acne and rosacea. Dermatol Clin 2000; 18: 63-71.
Wilkins J. Treatment of rosacea: topical clyndamicin versus oral tetraciclin. Int J Dermatol 1993; 32: 65-67.
Dahl MV. Topical metronidazole maintains remission of rosacea. Arch Dermatol 1998; 134: 679-683.
Wilkin J. The use of topical product of maintaining remission of rosacea. Arch Dermatol 1999; 135: 79-80.
Rebora A. Rosacea. J Invest Dermatol 1988; 3(suppl): 56s-59s.
Ertl G. A comparison of the efficacy of topical and low dose oral isotretinoin in rosacea. Arch Dermatol 1994; 130: 319-324.
Full text